Pamela Demain

Pamela Demain has extensive work experience in the biopharmaceutical industry. Pamela has held various leadership roles in business development, consulting, and relationship management.

In 2000, Pamela joined Merck & Co., Inc. as the Executive Director and Head of Relationship Management, Business Development, and Licensing. Pamela was responsible for negotiating complex transactions and leading the relationship management function. Pamela held this role until 2016.

Prior to their time at Merck, Pamela worked at Gruppo Lepetit as a Laboratory Technician and later at the Massachusetts Institute of Technology as a Laboratory Technician in various departments.

After retiring from Merck in 2016, Pamela founded Pamela R Demain Consulting. Pamela served as the President, leading strategic business development for biotech clients. Pamela also served as the President of the Licensing Executives Society (U.S.A. and Canada), Inc. in 2014 and 2015.

In 2019, Pamela joined Flame Biosciences as the Senior Vice President of Business Development. Pamela held this role until 2023.

Currently, Pamela is the Senior Vice President of Business Development at NImmune Biopharma, Inc.

Throughout their career, Pamela has demonstrated strong expertise in strategic business development, negotiation, and leadership. Pamela is open to new board and consulting opportunities.

Pamela Demain earned their Bachelor's degree from the University of Massachusetts Amherst, where they studied from 1971 to 1975. Pamela then pursued further education and obtained an MBA in International Business from The American University, attending from 1978 to 1980.

In addition to their formal education, Pamela Demain obtained a certification as a Certified Licensing Professional from CLP, Inc. in 2009. The exact month of obtaining this certification is not provided.